x
Breaking News
0

Biotron Ltd (BIT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.019 0.000    0.00%
19/10 - Closed. Currency in AUD ( Disclaimer )
Type: Equity
Market: Australia
ISIN: AU000000BIT4 
  • Volume: 0
  • Bid/Ask: 0.018 / 0.019
  • Day's Range: 0.018 - 0.019
Start Trading with Nadex
Biotron Ltd 0.019 0.000 0.00%

BIT Overview

 
Information about the Biotron Ltd Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.019
Day's Range0.018 - 0.019
Revenue3.21M
Open0.018
52 wk Range0.016 - 0.048
EPS - 0.01
VolumeN/A
Market Cap7.45M
Dividend (Yield)0 (N/A)
Average Volume (3m)501,070
P/E RatioN/A
Beta1.13
1-Year Change - 59.57%
Shares Outstanding392,299,816
Next Earnings DateN/A

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Neutral Neutral Sell Buy Strong Sell
Technical Indicators Neutral Sell Neutral Strong Buy Strong Sell
Summary Neutral Neutral Neutral Strong Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Doji Star Bearish 1W Current
Three Outside Up 1M Current
Completed Patterns
Bullish Engulfing 1M 1 Sep 17
Bullish doji Star 1M 2 Aug 17
Dark Cloud Cover 1W 2 Oct 01, 2017

Biotron Ltd News & Analysis

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  A2 Milk Company Ltd 7.130 7.130 6.980 +0.030 +0.42% 3.49M 20/10  
  Telstra Corporation. 3.520 3.530 3.460 +0.010 +0.28% 22.29M 20/10  
  Commonwealth Bank Australia 78.970 79.190 78.400 +0.230 +0.29% 1.83M 20/10  
  Galaxy Resources 3.770 3.820 3.730 -0.070 -1.82% 4.79M 20/10  
  Pilbara Minerals Ltd 0.750 0.765 0.740 -0.020 -2.60% 11.35M 20/10  
  BHP Billiton Ltd 26.680 26.770 26.355 +0.120 +0.45% 6.54M 20/10  
  ANZ Banking Group 30.590 30.740 30.260 -0.010 -0.03% 3.18M 20/10  
  National Australia Bank 32.460 32.560 32.170 +0.080 +0.25% 2.73M 20/10  
  Bellamys Australia Ltd 11.930 12.290 11.730 -0.270 -2.21% 1.32M 20/10  
  Bubs Australia 0.6450 0.6750 0.6400 -0.0200 -3.01% 5.92M 20/10  

Biotron Ltd Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

4

Equity Type

ORD

Biotron Limited is an Australia-based biotechnology company. The Company is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. The Company is focused on the ongoing clinical development of its antiviral platform. The Company's lead antiviral drug, BIT225 is in mid-stage clinical development with approximately eight clinical trials completed. The Company has conducted clinical trails in human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV) and HIV-1/HCV co-infected population. The clinical trials showed that BIT225 targets and reduces levels of HIV-1 residing in long-lived monocyte/macrophage reservoirs. BIT225 has clinical antiviral activity against both HIV-1 and HCV. BIT225 is pan-genotypic and is active against all HCV genotypes, including GT3. The Company designs and develops drugs that target a class of virus protein known as viroporins. Its earlier stage programs include Dengue, Influenza and others.

Read More

My Sentiments

What is your sentiment on Biotron Ltd?
or
Market is currently closed. Voting is open during market hours.

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Biotron Ltd
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
 
 
 
Add Chart to Comment
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email